17.06MMarket Cap-550P/E (TTM)
2.4800High2.4075Low13.47KVolume2.4400Open2.3900Pre Close33.10KTurnover0.25%Turnover RatioLossP/E (Static)6.99MShares13.490052wk High-0.47P/B13.26MFloat Cap2.286452wk Low--Dividend TTM5.44MShs Float126.7200Historical High--Div YieldTTM3.03%Amplitude1.2600Historical Low2.4570Avg Price1Lot Size
Minerva Neurosciences Stock Forum
$Infobird Software(IFBD.US)$ $Ascent Solar Technologies(ASTI.US)$ $Rail Vision(RVSN.US)$ $J-Long Group(JL.US)$ $Minerva Neurosciences(NERV.US)$
📊⚡️📊
Roluperidone NDA receives CRL from FDA 🙁
⚠️ FDA cited clinical deficiencies:
▪️ Insufficient substantial evidence of effectiveness
▪️ lacks data on concomitant antipsychotic admin.
▪️ lacks data to establish change in negative symptoms of schizophrenia
▪️ inadequate number of subjects exposed at proposed dose
ℹ️Add'l info on Roluperidone…
⇒ for negative symptoms of schizophrenia
⇒ NDA
⇒ PDUFA: 02/26/24
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
No comment yet